Abstract
Nore and RASSF1A are noncatalytic proteins that share 50% identity over their carboxyterminal 300 AA, a segment that encompasses a putative Ras-Rap association (RA) domain. RASSF1 is expressed as several splice variants, each of which contain an RA domain, however the 340 AA RASSF1A, but not the shorter RASSF1C variant, is a putative tumor suppressor. Nore binds to Ras and several Ras-like GTPases in a GTP dependent fashion however neither RASSF1 (A or C) or the C. elegans Nore/RASSF1 homolog, T24F1.3 exhibit any interaction with Ras or six other Ras-like GTPases in a yeast two-hybrid expression assay. A low recovery of RASSF1A (but not RASSF1C) in association with RasG12V is observed however on transient expression in COS cells. Nore and RASSF1A can each efficiently homodimerize and heterodimerize with each other through their nonhomologous aminoterminal segments. Recombinant RASSF1C exhibits a much weaker ability to homodimerize or heterodimerize; thus the binding of RASSF1C to Nore is very much less than the binding of RASSF1A to Nore. The association of RASSF1A with RasG12V in COS cells appears to reflect the heterodimerization of RASSF1A with Nore, inasmuch the recovery of RASSF1A with RasG12V is increased by concurrent expression of full length Nore, and abolished by expression of Nore deleted of its RA domain. The preferential ability of RASSF1A to heterodimerize with Nore and thereby associate with Ras-like GTPases may be relevant to its putative tumor suppressor function.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Akasaka K, Tamada M, Wang F, Kariya K-i, Kikuchi A, Yamamoto M, Shirouzu M, Yokoyama S, Kataoka T . 1996 J. Biol. Chem. 271: 5353–5360
Avruch J, Zhang X-f, Kyriakis JM . 1994 TIBS. 19: 279–283
Avruch J, Khokhlatchev A, Kyriakis JM, Luo Z, Tzivion G, Vavvas D, Zhang X-f . 2001 Recent Prog. Horm. Res. 56: 127–155
Barr MM, Tu H, Van Aelst L, Wigler M . 1996 Mol. Cell. Biol. 16: 5597–5603
Dammann R, Li C, Yoon J-H, Chin PL, Bates S, Pfeifer DP . 2000 Nat. Genet. 25: 315–319
Durfee T, Becherer K, Chen P, Yeh SH, Yan Y, Kilurn AE, Lee WH, Elledge SJ . 1993 Genes Dev. 7: 555–569
Ehrhardt GRA, Korherr C, Wieler JS, Knaus M, Schrader JW . 2001 Oncogene 20: 188–197
Feig LA, Cantor T, Cantor S . 1996 Trends Biochem. Sci. 11: 438–431
Gotz RA, Ehrhardt LKB, Lee F, Wieler JS, Schrader JW . 1999 Blood 94: 2433–2444
Han L, Wong D, Dhaka A, Afar D, White M, Xie W, Herschman H, Witte O, Colicelli J . 1997 Proc. Natl. Acad. Sci. USA 94: 494–4959
Huang L, Weng X, Hofer F, Martin GS, Kim SH . 1997 Nat. Struct. Biol. 4: 609–615
Inouye K, Mizutani S, Koide H, Kaziro Y . 2000 J. Biol. Chem. 275: 3738–3740
Kalhammer G, Bahler M, Schmits M, Schmitz F, Jockel J, Block C . 1997 FEBS. 414: 599–602
Keikhoft E, Rapp UR . 1998 Oncogene 17: 1457–1462
Kelley GG, Reks SE, Ondrako JM, Smrcka AV . 2001 EMBO J. 20: 743–754
Kuriyama M, Harada N, Kuroda S, Yamamoto T, Nakafuku M, Iwamatsu A, Yamoto D, Prasad R, Croce C, Canaani E . 1996 J. Biol. Chem. 271: 607–610
Lerman MI, Minna JD . 2000 Cancer Res. 60: 6116–6133
Luo Z, Tzivion G, Belshaw PJ, Marshall M, Avruch J . 1996 Nature 383: 181–185
Morrison DK, Cutler Jr RE . 1997 Curr. Opin. Cell Biol. 274: 174–179
Nassar N, Horn G, Herrmann C, Scherer A, McCormick F, Wittinghofer A . 1995 Nature 375: 554–560
Ohba Y, Mochizuki N, Yamashita S, Chan AM, Schrader JW, Hattori S, Nagashima K, Matsuda M . 2000 J. Biol. Chem. 275: 20020–20026
Ponting CP, Benjamin DR . 1996 TIBS. 21: 422–425
Quilliam LA, Castro AF, Rogers-Graham KS, Martin CB, Der CJ, Bi C . 1999 J. Biol. Chem. 274: 23850–23857
Reuther GW, Der CJ . 2000 Curr. Biol. 12: 157–165
Rodriquez-Viciana P, Warne PH, Dhand R, Vanhaesebroeck B, Gout I, Fry MJ, Waterfield MD, Downward J . 1994 Nature 370: 527–532
Rodriquez-Viciana P, Warne PH, Khwaja A, Marte BM, Pappin D, Das P, Waterfield MD, Ridley A, Downward J . 1997 Cell 89: 457–467
Rodriquez-Viciana P, Warne PH, Vanhaesebroeck B, Waterfield MD, Downward J . 1996 EMBO J. 15: 2442–2451
Rubin GM, Yandell MD, Wortman JR, Gabor Miklos GL, Nelson CR, Hariharan IK, Fortini ME, Li PW, Apweiler R, Fleischmann W, Cherry JM, Henikoff S, Skupski MP, Misra S, Ashurner M, Birney W, Boguski MS, Brody T, Brokstein P, Celniker SE, Chervitz SA, Coates D, Cravchik A, Gabrielian A, Galle RF, Gelbart WM, George RA, Goldstein LSB, Gong F, Guan P, Harris NL, Hay BA, Hoskins RA, Li J, Li Z, Hynes RO, Jones SJM, Kuehl PM, Lamaitre B, Littleton JT, Morrison DK, Mungall C, O'Farrell PH, Pickeral OK, Shue C, Vosshall LB, Zhang J, Zhao Q, Zheng ZH, Zhong F, Zhong W, Gibbs R, Vener JC, Adams MD, Lewis S . 2000 Science 287: 2204–2215
Shibatohge M, Kariya K, Liao Y, Hu C-D, Watari Y, Goshima M, Shima F, Kataoka T . 1998 J. Biol. Chem. 273: 6218–6222
Shields JM, Pruitt K, McFall A, Shaub A, Der CJ . 2000 Cell. Biol. 4: 147–154
Shima F, Yamawaki-Kataoka Y, Yanagihara C, Tamada M, Okada T, Kariya K-i, Kataoka T . 1997 Mol. Cell. Biol. 17: 1057–1064
Stewart S, Guan KL . 2000 J. Biol. Chem. 275: 8854–8862
Song C, Hu C-D, Masago M, Kariya K-i, Yamawaki-Kataoka Y, Shibatohge M, Wu D, Satoh T, Kataoka T . 2001 J. Biol. Chem. 276: 2752–2757
Vavvas D, Li X, Avruch J, Zhang X-f . 1998 J. Biol. Chem. 273: 5439–5442
Vos MD, Ellis CA, Bell A, Birrer MJ, Clark GJ . 2000 J. Biol. Chem. 275: 35669–35672
White MA, Vale T, Chamonis JH, Schaefer E, Wigler MHL . 1996 J. Biol. Chem. 271: 16439–16442
Wolthuis RM, Bos JL . 1999 Curr. Opin. Genet. Dev. 1: 112–117
Zhang Z, Wang Y, Vikis HG, Johnson L, Liu G, Li J, Anderson MW, Sills RC, Hong HL, Devereux TR, Jacks T, Guan K-L, You M . 2001 Nat. Genet. 29: 25–33
Acknowledgements
We thank Lawrence Quilliam for M-Ras constructs, and Christian Herrmann for Rap 2A, TC21 and R-Ras. Chris Ponting provided helpful discussion. S Ortiz-Vega is supported by NIH T32DK07028. A Khokhlatchev is supported by the Leukemia and Lymphoma Society of America. GP Pfeifer was supported by a grant from the University of California Tobacco Related Disease Research Program (9RT-0175).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ortiz-Vega, S., Khokhlatchev, A., Nedwidek, M. et al. The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1. Oncogene 21, 1381–1390 (2002). https://doi.org/10.1038/sj.onc.1205192
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205192
Keywords
This article is cited by
-
In silico analysis predicting effects of deleterious SNPs of human RASSF5 gene on its structure and functions
Scientific Reports (2020)
-
NORE1A directs apoptotic switch of TNF signaling through reciprocal modulation of ITCH-mediated destruction of TNFRI and BAX
Oncogene (2020)
-
Signaling pathways and clinical application of RASSF1A and SHOX2 in lung cancer
Journal of Cancer Research and Clinical Oncology (2020)
-
Cytogenetic characterization of the malignant primitive neuroectodermal SK-PN-DW tumor cell line
BMC Cancer (2019)
-
New type of interaction between the SARAH domain of the tumour suppressor RASSF1A and its mitotic kinase Aurora A
Scientific Reports (2019)